Final 4-year results of the RAINBOW real-world study: intravitreal aflibercept dosing regimens in France in treatment-naïve patients with neovascular age-related macular degeneration

PURPOSE: The purpose of this study is to evaluate real-world treatment outcomes in patients with neovascular age-related macular degeneration (nAMD) treated with intravitreal aflibercept (IVT-AFL) in routine clinical practice in France. METHODS: RAINBOW (NCT02279537) was an ambispective, observation...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Salomon-Yves, Dominguez, Marcel, Coscas, Florence, Faure, Céline, Baillif, Stéphanie, Oubraham, Hassiba, Kodjikian, Laurent, Weber, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Retinal Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049954/
https://www.ncbi.nlm.nih.gov/pubmed/36399178
http://dx.doi.org/10.1007/s00417-022-05900-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049954/
https://www.ncbi.nlm.nih.gov/pubmed/36399178
http://dx.doi.org/10.1007/s00417-022-05900-6

Ejemplares similares